ADAM17 |
ADAM metallopeptidase 17 |
AP-1 |
activator protein 1 |
ATC |
anaplastic thyroid cancer |
BAA |
bead aggregation assays |
CAM |
cell adhesion molecule |
CD |
carboxyl-terminal domain |
CSC |
cancer stem cells |
CTC |
circulating tumor cells |
CTE |
congenital tufting enteropathy |
CTSL |
cathepsins L |
DTCs |
disseminated tumor cells |
ECM |
extracellular matrix |
EGFR |
epidermal growth factor receptor |
ERK |
extracellular signal-regulated kinases |
EpCAM |
epithelial cell adhesion molecular |
EpEX |
EpCAM extracellular domain |
EpICD |
EpCAM intracellular domain |
FHL2 |
four-and-a-half LIM domains 2 |
FILM-FRET |
fluorescence-lifetime imaging based Förster resonance energy transfer |
EMT |
epithelial-to-mesenchymal transition |
JMJD2D |
histone lysine demethylase 4D |
kb |
kilobases |
kD |
kilodalton |
LC |
Langerhans cells |
LEF1 |
lymphoid enhancer binder factor 1 |
MET |
mesenchymal-to-epithelial transition (MET) |
MMPs |
matrix metallopeptidases |
ND |
N-terminal domain |
nPKC |
novel protein kinase C |
OCT4 |
octamer-binding transcription factor 4 |
PDTC |
poorly differentiated thyroid cancer |
PSEN2 |
presenilin 2 |
RIP |
regulated intramembrane proteolysis |
shRNA |
short-hairpin RNA |
SAXS |
small angle X-ray scattering |
SP |
signal peptide |
TACE |
tumor necrosis factor-α-converting enzyme |
TCF4 |
transcription factor 4 |
TGF-β1 |
transforming growth factor- β1 |
TNBC |
triple negative breast cancer |
TM |
transmembrane |
TY-1 |
type-1 thyroglobulin |
ZO-1 |
zona occludens-1 |